Literature DB >> 116310

Radiobiological data for clinical dosimetry in pion tumour therapy.

I R Heyder, W Pohlit.   

Abstract

Ehrlich ascites tumour cells were irradiated with negative pions at different positions in the plateau and the peak of the depth absorbed dose curve. Dose-survival curves for immediate testing of the viability of the cells are given and are compared with other types of radiations in use for therapy. From the data obtained after repair of potentially lethal damage effective survival curves for fractionated irradiation are evaluated.

Entities:  

Mesh:

Year:  1979        PMID: 116310     DOI: 10.1007/bf01358286

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  4 in total

1.  Quantitative aspects of repair of potentially lethal damage in mammalian cells.

Authors:  G Iliakis; W Pohlit
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1979-12

2.  A cybernetic model for radiation reactions in living cells. I. Sparsely-ionizing radiations; stationary cells.

Authors:  A Kappos; W Pohlit
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1972-07

3.  Proliferation of lethally damaged mammalian cells irradiated by fast electrons, fast neutrons, alpha particles, and pions.

Authors:  I R Heyder; W Pohlit
Journal:  Radiat Res       Date:  1980-05       Impact factor: 2.841

4.  Optimization of cancer therapy: Part II--Effects of combining 2-deoxy-D-glucose treatment with gamma-irradiation on sarcoma-180.

Authors:  V K Jain; W Porschen; L E Feinendegen
Journal:  Indian J Exp Biol       Date:  1977-09       Impact factor: 0.818

  4 in total
  2 in total

Review 1.  Radiation physics.

Authors:  H Blattmann
Journal:  Experientia       Date:  1989-01-15

2.  Effect of negative pi mesons on vascular permeability of brain in neonatal rats.

Authors:  R Landolt; D Arn; H Blattmann; I Cordt; H Fritz-Niggli
Journal:  Radiat Environ Biophys       Date:  1979-08-10       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.